Physician

Cameron James Oswalt, MD

According to 2025 Medicare claims, Cameron Oswalt, MD (NPI: 1093211815) practices medical oncology in the Durham-Chapel Hill, NC market, with the plurality of this provider's patient population coming from Durham, NC. This provider's primary affiliated billing organization is DUKE HEALTH INTEGRATED PRACTICE, INC. (NPI: 1205553369; TIN: 862109896) and primary practice location at 27710-2000. Oswalt is affiliated with the Duke Connected Care, LLC (ACO ID: A2419), participating under the MSSP model.

Oswalt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 46 traditional Medicare patients, billed 213 HCPCS/CPT codes, and received $15,780 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 220 prescription claims across 38 beneficiaries totaling $134,749 in drug costs, led by Abiraterone Acetate (Abiraterone Acetate). Open Payments data shows 5 records totaling $635. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $14,566 to $134,749. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$7.9K$16K2024 Medicare payment: $15,780 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
202446213$15,780

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$67K$135K2018 Drug cost: $14,566 (USD; Tot_Drug_Cst)2019 Drug cost: $76,839 (USD; Tot_Drug_Cst)2020 Drug cost: $33,015 (USD; Tot_Drug_Cst)2021 Drug cost: $17,166 (USD; Tot_Drug_Cst)2022 Drug cost: $3,142 (USD; Tot_Drug_Cst)2023 Drug cost: $37,801 (USD; Tot_Drug_Cst)2024 Drug cost: $134,749 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20183191$14,566
201979407$76,839
202078449$33,015
202154255$17,166
20223290$3,142
202325138$37,801
202438220$134,749

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more1111$135
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes1212$129
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more2155$108
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes1552$88
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's2365$12

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Abiraterone AcetateAbiraterone Acetate18540$8,013
GabapentinGabapentin11498$164
Prochlorperazine MaleateProchlorperazine Maleate14100$129
PrednisonePrednisone24698$112
Oxycodone HclOxycodone Hcl12130$103

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$635AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Cameron James Oswalt, MD?

Tedicare shows public-source Medicare data for Cameron James Oswalt, MD (NPI 1093211815), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Cameron James Oswalt, MD have ACO affiliation data?

Cameron James Oswalt, MD is shown with ACO affiliation data for Duke Connected Care, LLC (MSSP, ACO ID A2419).

What billing organization is linked to Cameron James Oswalt, MD?

Cameron James Oswalt, MD is linked to DUKE HEALTH INTEGRATED PRACTICE, INC. (billing NPI 1205553369) in the available physician profile data.

Does Cameron James Oswalt, MD have Open Payments data?

Cameron James Oswalt, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.